Phase II study of roniciclib in combination with cisplatin/etoposide or carboplatin/etoposide as first-line therapy in subjects with extensive-disease small cell lung cancer (ED-SCLC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; p. vi494
Main Authors Reck, M., Horn, L., Novello, S., Barlesi, F., Albert, I., Juhasz, E., Chung, J., Fritsch, A., Drews, U., Rutstein, M., Wagner, A., Govindan, R.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2016
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw389.04